Evidence map›Paper›PMID 41162387›Full record

ArticleNature communications2025

Catalytic asymmetric synthesis of (N, N)- spiroketal via Pd-catalyzed enantioconvergent aminocarbonylation and dearomative nucleophilic aza-addition.

Lei Su, Shen Gao, Jiawang Liu

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lei SuFrontiers Science Center for Transformative Molecules, State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Shen GaoFrontiers Science Center for Transformative Molecules, State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China. gaoshen2000@sjtu.edu.cn.ORCID http://orcid.org/0009-0004-8821-2936
Jiawang LiuFrontiers Science Center for Transformative Molecules, State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China. liujw2020@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-8548-6286

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22201173National Natural Science Foundation of China (National Science Foundation of China) 22571192
6 · The paper itself

Abstract

Chiral spirocyclic skeletons have found widespread applications in asymmetric catalysis, drug discovery, and functional materials due to their rigid three-dimensional architecture and excellent stereochemical stability. However, the structural diversity of accessible spiro frameworks remains limited, constraining their broader utility and functional development. For instance, chiral (N, N)-spiroketals represent a promising class of scaffolds with potential application in asymmetric catalysis and are frequently encountered in natural products and biologically active compounds, yet their efficient synthesis is still underdeveloped. Herein, we present a Pd-catalyzed cascade enantioconvergent aminocarbonylation and intramolecular dearomative nucleophilic aza-addition that enables the efficient synthesis of chiral (N, N)-spiroketal. This formal [3 + 1 + 1] spiroannulation employs racemic quinazoline-derived heterobiaryl triflates, carbon monoxide, and amines to deliver an array of (N, N)-spiroketal in high yields and excellent enantioselectivities. The protocol exhibits wide functional group tolerance, scalability, and downstream synthetic utility, providing access to structurally diverse spirocyclic derivatives. Mechanistic studies reveal that the stereochemical outcome of (N, N)-spiroketal is determined by the atroposelective DyKAT aminocarbonylation step, rather than the subsequent spiroannulation. Moreover, the resulting spiroketal structure has been developed into chiral carbene ligand, as demonstrated by the successful synthesis of its corresponding Rh, Ir, Au and Pd complexes.

Identifiers

PMID41162387
PMCPMC12572194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.